Enter your details to join our mobile app waitlist and receive early access to the Bell Direct App.
Over in the US on Tuesday, stocks closed higher as investors shift focus from Trump’s trade wars to fourth quarter earnings results. The Nasdaq rose 1.35%, the S&P500 gained 0.72% and the Dow Jones ended the day up 0.3%. Palantir, the big data analytics software provider, soared 24% on Tuesday to become a $200bn company after posting Q4 results that topped expectations.
In Europe overnight, markets closed mostly higher amid Trump’s tariffs pauses with Mexico and Canada and on the back of strong key corporate results out in the region. The STOXX 600 rose 0.3%, Germany’s DAX added 0.4%, the French CAC climbed 0.7%, and, in the UK, the FTSE100 ended the day down 0.15%.
Across the APAC region on Tuesday, markets rallied as China retaliated to Trump’s tariffs by slapping tariffs on US imports between 10% to 15% for certain goods. Hong Kong’s Hang Seng rose 2.83%, Japan’s Nikkei added 0.72%, South Korea’s Kospi index climbed 1.13% and China’s CSI index remains closed for the Lunar holiday.
Locally yesterday the ASX posted a slight loss of 0.06% yesterday as investors responded to Trump’s tariffs on China coming into effect and the late afternoon retaliation of Beijing placing a 10-15% tariff on certain goods from the US. On Monday, Trump suspended tariffs on Mexico and Canada as discussions between the regions began, while the tariffs in China came into effect late on Tuesday AU time. Tech stocks offset some of the heavy losses yesterday with a gain for the sector of 1.52%, while REIT and consumer discretionary stocks fell 1.06% and 0.76% respectively.
Online jobs advertisement platform Seek’s proposed acquisition of Xref for a value of $42.1m fell through yesterday after Xref’s shareholder voted against the takeover bid. Shares in Xref tumbled 22.6% yesterday while shares in Seek fell just 0.2%.
Crop protection solution producer Nufarm rallied over 3% on Tuesday after reporting a positive trading update including the expectation to achieve $100m from its omega-3 revenue in FY25 and its belt-tightening program for cost cutting remains on track with $50m of annualised savings.
What to watch today:
Trading Ideas: